1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Depression, Involutional in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, X; Huang, R; Wang, M; Wang, S; Yang, L; Zhu, R; Zhuang, X | 1 |
1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Depression, Involutional
| Article | Year |
|---|---|
Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles.
Topics: Animals; Antidepressive Agents; Apoptosis; Behavior, Animal; Corticosterone; Curcumin; Depressive Disorder, Major; Disease Models, Animal; Dopamine; Dronabinol; Drug Carriers; Lipids; MAP Kinase Kinase 1; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nanoparticles; PC12 Cells; Rats; Receptor, Cannabinoid, CB1 | 2017 |